MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Clinico-radiological Phenotype of a Unique Family with Mutations in PRKN Over Three Decades

    M. Li, W. Liu, R. Mackinnon, C. Sue (Randwick, Australia)

    Objective: To report the clinico-radiological phenotype and progression of a female proband and her parents with mutations in the PRKN gene. Background: Bi-allelic PRKN mutations…
  • 2026 International Congress

    Suicidal Ideation and Behavior in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    S. Kuanar, A. Mahapatra (Bhubaneswar, India)

    Objective: Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects both motor and non-motor neurological functions. In addition to motor impairment, patients frequently experience…
  • 2026 International Congress

    5-year Longitudinal Changes in Non-motor Symptoms and Their Association With Motor Progression in Parkinson’s Disease

    S. Heinzel, Q. Destani-Dauti, M. Hobert, W. Maetzler, D. Berg (Kiel, Germany)

    Objective: To examine longitudinal relationships between non-motor symptoms (NMS) and motor progression in Parkinson’s disease (PD), and to determine whether baseline NMS predict motor decline…
  • 2026 International Congress

    Physical Activity is Associated with Attenuated Motor and Cognitive Progression in Parkinson’s Disease

    DW. Ryu, KR. Duque, J. Abanto, L. Marsili, NC. Paredes, AH. Gorriti, H. Deraz, E. Hill, A. Duker, AJ. Espay (Seoul, Republic of Korea)

    Objective: To determine whether physical activity (PA) modifies the rate of motor and cognitive progression in Parkinson’s disease (PD) and to identify specific components of…
  • 2026 International Congress

    Impact of Alpha-Synuclein Burden and Cellular Stress on GBA-PD Macrophage

    V. Lentini, G. Uras, D. Moreno-Martinez, S. Lucas, A. Pantaleo, D. Hughes (London, United Kingdom)

    Objective: This study explores how non-neuronal dysfunction drives the rapid progression of GBA-PD, aiming to identify therapeutic targets that restore protein degradation and cellular stability.…
  • 2026 International Congress

    Role of ApoE in α-Synuclein Pathology

    A. Jaafar, E. Sierecki (Sydney, Australia)

    Objective: To investigate whether apolipoprotein E (ApoE) isoforms directly interact with α-synuclein and determine how these interactions influence aggregation dynamics and cellular uptake. Background: The…
  • 2026 International Congress

    Multi-Omics Analysis Reveals Brain and Biofluid Molecular Changes Induced by Chronic Sleep Fragmentation in a Prodromal Parkinson’s Disease Mouse Model

    H. Yagihara, M. Miyazaki, K. Ueda, H. Yamakado, E. Minakawa (Kodaira, Japan)

    Objective: To investigate the molecular mechanisms by which chronic sleep fragmentation accelerates the progression of prodromal Parkinson’s disease (PD). Background: Recent epidemiological studies suggest that…
  • 2026 International Congress

    Clinical impact of local field potential sensing–guided deep brain stimulation: a real‑world registry

    J. Youn, S. Bick, P. Konrad, M. Schiess, T. Theys, T. Witt, H. Mure, H. Oshima, K. Kimura, G. Oyama, H. Kishima, N. Murase, Y. Tsuboi, A. Fasano, T. Brionne, I. Buffin, G. Choi, X. Sun, Y. Ren, T. Weaver (Seoul, Republic of Korea)

    Objective: To evaluate the association between Local Field Potential (LFP) sensing use and patient outcomes (EuroQol 5-Dimensions (EQ5D), medications), as well as device-related outcomes by…
  • 2026 International Congress

    Longitudinal Changes and Clinical utility of the Neurological Pupillary Index in De Novo Parkinson’s Disease

    JSL. Lee, SY. You (Daegu, Republic of Korea)

    Objective: To characterize longitudinal changes in pupillometric parameters in de novo Parkinson’s disease and explore their associations with clinical severity and disease progression. Background: Automated…
  • 2026 International Congress

    STEM-PD: An open-label phase I/II trial of transplanted human pluripotent stem cell-derived dopaminergic progenitor cells in Parkinson’s disease

    G. Paul, H. Bjartmarz, A. Kirkeby, J. Nelander, R. Smith, S. Kayhanian, A. Evans, B. Harry, E. Cutting, S. Fazal, N. Lao-Kaim, T. van Vliet, I. Grubor, O. Hansson, P. Picchini, O. Lindvall, A. Björklund, H. Widner, M. Parmar, R. Barker (Lund, Sweden)

    Objective: The STEM-PD trial evaluates safety, tolerability, and feasibility of intraputaminal transplantation of STEM-PD, a dopaminergic(DA) progenitor product derived from a clinical-grade human embryonic stem…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley